☆ 4.6 Editorial Material

AKR1C3 inhibition therapy in castration-resistant prostate cancer and breast cancer: lessons from responses to SN33638

FRONTIERS IN ONCOLOGY (2014)

Journal

FRONTIERS IN ONCOLOGY

Volume 4, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA

DOI: 10.3389/fonc.2014.00162

Keywords

AKR1C3; SN33638; castration-resistant prostate cancer; breast cancer; testosterone; 17 beta-estradiol

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.